Mahesh V Patel - 02 Jan 2025 Form 4/A - Amendment Insider Report for Lipocine Inc. (LPCN)

Role
Chief Executive Officer, Director
Signature
/s/ Mahesh V. Patel
Issuer symbol
LPCN
Transactions as of
02 Jan 2025
Net transactions value
+$49,536
Form type
4/A - Amendment
Filing time
02 Jan 2025, 19:47:51 UTC
Date Of Original Report
30 Dec 2024
Previous filing
30 Dec 2024
Next filing
19 Dec 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPCN Stock Option (Right to Buy) Award $49,536 +10,320 +8.4% $4.80 132,688 23 Dec 2024 Common Stock 10,320 $4.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to vesting whereby 1/3 of the shares subject to the award will vest on December 23, 2025, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years.